Dear Frank, that's why I sent it on when she asked a second time because I
knew you don't get to see it all.  Will forward to LN.  Sincerely, Pat in
SNJ
-----
> Dear Pat,
> I have had no personal or previous experience with this drug, so all I can
> offer is based on Hale's presentation on which the mother has based her
> decision to continue to breastfeed.
> First of all Hale states that no pediatric concerns have been reported so
> far.  That means either no one has ever taken the drug and breastfed
before,
> or those that have done so have encountered no problems.
> Secondly, L4 states more than just "hazardous"."  It also states that "the
> benefits from use in breastfeeding mothers may be acceptable despite the
> risk to the infant."
> What should the mother monitor for in the infant: the same as with
herself.
> Monitor for edema in the infant and monitor urine output.  If edema occurs
> or urine output decreases, stop breastfeeding and have the infant
medically
> checked.
> As I stated, the mother has read all of Hale's information and made an
> educated and personal decision to continue to breastfeed knowing the risks
> and benefits and what to monitor for.
> Hope this helps.
> Sorry, I missed the LACTNET posting on this.  Because of the volume of
> emails I receive, I usually go off LACTNET if I am going to be away for at
> least three days (and depend upon people like you to catch me up!).
> Take care.
> Frank

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html